tiprankstipranks
Trending News
More News >
Sionna Therapeutics reports Q4 EPS ($3.38) vs. ($3.93) last year
PremiumThe FlySionna Therapeutics reports Q4 EPS ($3.38) vs. ($3.93) last year
4M ago
Sionna Therapeutics sees cash runway into 2028
Premium
The Fly
Sionna Therapeutics sees cash runway into 2028
4M ago
Okta upgraded, Quest Diagnostics downgraded: Wall Street’s top analyst calls
Premium
The Fly
Okta upgraded, Quest Diagnostics downgraded: Wall Street’s top analyst calls
4M ago
Sionna Therapeutics initiated with a Buy at Guggenheim
PremiumThe FlySionna Therapeutics initiated with a Buy at Guggenheim
4M ago
Sionna Therapeutics: Promising NBD1 Stabilizers Poised to Challenge Vertex in the $11 Billion CF Market
Premium
Ratings
Sionna Therapeutics: Promising NBD1 Stabilizers Poised to Challenge Vertex in the $11 Billion CF Market
4M ago
Sionna Therapeutics: Innovative NBD1 Stabilizers and Strategic Synergies Drive Buy Rating
Premium
Ratings
Sionna Therapeutics: Innovative NBD1 Stabilizers and Strategic Synergies Drive Buy Rating
4M ago
Opening Day: AI mobility provider, steel veteran make trading debuts
PremiumThe FlyOpening Day: AI mobility provider, steel veteran make trading debuts
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100